It’s important for clinicians to assess patients undergoing percutaneous coronary intervention (PCI) for both anemia and chronic kidney disease (CKD).

Ojjaara helps patients with myelofibrosis by reducing spleen size, easing symptoms, and improving anemia to boost ...